These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Role of the pineal gland in endocrine regulation]. Antón Tay F Rev Invest Clin; 1973; 25(3):199-210. PubMed ID: 4585866 [No Abstract] [Full Text] [Related]
3. Melatonin and parkinsonism. Papavasiliou PS; Cotzias GC; Düby SE; Steck AJ; Bell M; Lawrence WH JAMA; 1972 Jul; 221(1):88-9. PubMed ID: 5067774 [No Abstract] [Full Text] [Related]
4. On the effect of melatonin upon human brain. Its possible therapeutic implications. Antón-Tay F; Díaz JL; Fernández-Guardiola A Life Sci I; 1971 Aug; 10(15):841-50. PubMed ID: 5566131 [No Abstract] [Full Text] [Related]
5. [Indications for the conservative and surgical management of Parkinsonism]. Metzel E Neurochirurgia (Stuttg); 1970 Sep; 13(5):169-73. PubMed ID: 4917950 [No Abstract] [Full Text] [Related]
6. Melatonin Treatment of Visual Hallucinations in Parkinson Disease. Delucca BJ; Richardson RM; Stewart JT J Clin Psychopharmacol; 2018 Oct; 38(5):532-534. PubMed ID: 30095559 [No Abstract] [Full Text] [Related]
8. A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism. Kelly JT; Zimmermann RL; Abuzzahab FS; Schiele BC Pharmacology; 1974; 12(2):65-73. PubMed ID: 4610599 [No Abstract] [Full Text] [Related]
10. [Use of L-DOPA in the therapy of parkinsonism]. D'Andrea F; De Divitiis E; Signorelli CD; Cerillo A; Tedeschi G Rass Int Clin Ter; 1971 Feb; 51(4):193-221. PubMed ID: 4930734 [No Abstract] [Full Text] [Related]
11. [Evaluation of L-DOPA in Parkinsonism with special reference to the study by double-blind method]. Okajima T; Kubota A; Nakahara N; Takeda S; Shimomura K Naika; 1972; 29(2):335-43. PubMed ID: 4552443 [No Abstract] [Full Text] [Related]
12. Amantadine hydrochloride in the treatment of parkinsonism: a placebo-controlled double-blind study. Freedman BE; Getz E; MacGregor JM; Ames FR S Afr Med J; 1971 Apr; 45(16):435-7. PubMed ID: 4932339 [No Abstract] [Full Text] [Related]
13. Effect of amantadine on some psychomotor performances in Parkinsonism. A double blind study. Laitinen LV; Vilkki J Ann Clin Res; 1971 Aug; 3(4):207-11. PubMed ID: 4937341 [No Abstract] [Full Text] [Related]
14. Combined treatment of parkinsonism with L-dopa and amantadine. Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690 [No Abstract] [Full Text] [Related]
15. Aromatic amino acids and modification of parkinsonism. Cotzias GC; Van Woert MH; Schiffer LM N Engl J Med; 1967 Feb; 276(7):374-9. PubMed ID: 5334614 [No Abstract] [Full Text] [Related]
16. Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial. Appleton DB; Eadie MJ; Sutherland JM Med J Aust; 1970 Oct; 2(14):626-9. PubMed ID: 4920572 [No Abstract] [Full Text] [Related]